Year: 2021
Type: article
Abstract: A promising new Phase III study of MDMA plus psychotherapy for PTSD treatment by Mitchell and colleagues that appeared in Nature Medicine raises important new questions about the biology and optimal treatment of this disorder.
Source: Cell Reports Medicine
Institutions: Yale University, VA Connecticut Healthcare System
Language: English
Subfield: Clinical Psychology
Field: Psychology
Domain: Social Sciences
Open Access status: gold
Estimated APC paid: $5,200
OpenAlex ID: W3196006476
